InsidersTradesSigma
Track the Bruker Corporation stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €8.8bn. The latest transaction was filed on 17 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: MARK R MUNCH. The full history is accessible without an account.
Analysts rate Bruker Corporation Buy (bullish), based on 12 analysts. Average price target: US$58.75.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Bruker Corporation is a company that specializes in the development of scientific instruments and analytical solutions. It provides technologies for research and industry in fields such as biology, chemistry, and materials.